{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:26:59Z","timestamp":1767598019690},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00277-021-04561-5","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T21:02:12Z","timestamp":1631566932000},"page":"705-708","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms"],"prefix":"10.1007","volume":"101","author":[{"given":"Sanyun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"20","key":"4561_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood"},{"issue":"2","key":"4561_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1182\/bloodadvances.2016000208","volume":"1","author":"A Tefferi","year":"2016","unstructured":"Tefferi A et al (2016) Targeted deep sequencing in primary myelofibrosis. Blood Adv 1(2):105\u2013111","journal-title":"Blood Adv"},{"issue":"3","key":"4561_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1182\/blood-2015-07-661835","volume":"127","author":"JD Milosevic Feenstra","year":"2016","unstructured":"Milosevic Feenstra JD et al (2016) Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms. Blood 127(3):325\u2013332","journal-title":"Blood"},{"issue":"9","key":"4561_CR4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/ng.3361","volume":"47","author":"M Krauthammer","year":"2015","unstructured":"Krauthammer M et al (2015) Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas. Nat Genet 47(9):996\u20131002","journal-title":"Nat Genet"},{"issue":"19","key":"4561_CR5","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.7150\/thno.34070","volume":"9","author":"L Tong","year":"2019","unstructured":"Tong L et al (2019) Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics 9(19):5532\u20135541","journal-title":"Theranostics"},{"key":"4561_CR6","doi-asserted-by":"crossref","unstructured":"Skov V (2020) Next generation sequencing in MPNs. Lessons from the past and prospects for use as predictors of prognosis and treatment responses. Cancers (Basel) 12(8):2194","DOI":"10.3390\/cancers12082194"},{"issue":"4","key":"4561_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.celrep.2016.03.075","volume":"15","author":"M Giannakis","year":"2016","unstructured":"Giannakis M et al (2016) Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep 15(4):857\u2013865","journal-title":"Cell Rep"},{"issue":"5","key":"4561_CR8","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41375-019-0668-5","volume":"34","author":"S Bartels","year":"2020","unstructured":"Bartels S et al (2020) Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis. Leukemia 34(5):1364\u20131372","journal-title":"Leukemia"},{"issue":"1","key":"4561_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2353\/jmoldx.2009.080114","volume":"11","author":"W Ma","year":"2009","unstructured":"Ma W et al (2009) Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias. J Mol Diagn 11(1):49\u201353","journal-title":"J Mol Diagn"},{"issue":"19","key":"4561_CR10","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1074\/jbc.M709302200","volume":"283","author":"A Dusa","year":"2008","unstructured":"Dusa A et al (2008) Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2. J Biol Chem 283(19):12941\u201312948","journal-title":"J Biol Chem"},{"issue":"20","key":"4561_CR11","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1182\/blood-2012-05-430926","volume":"121","author":"AJ Mead","year":"2013","unstructured":"Mead AJ et al (2013) Impact of isolated germline JAK2V617I mutation on human hematopoiesis. Blood 121(20):4156\u20134165","journal-title":"Blood"},{"issue":"1","key":"4561_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.exphem.2015.09.006","volume":"44","author":"SA Brooks","year":"2016","unstructured":"Brooks SA et al (2016) JAK2(V617I) results in cytokine hypersensitivity without causing an overt myeloproliferative disorder in a mouse transduction-transplantation model. Exp Hematol 44(1):24\u20139.e1","journal-title":"Exp Hematol"},{"issue":"11","key":"4561_CR13","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1128\/MCB.24.11.4968-4978.2004","volume":"24","author":"EP Feener","year":"2004","unstructured":"Feener EP et al (2004) Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling. Mol Cell Biol 24(11):4968\u20134978","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4561_CR14","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-018-05768-3","volume":"9","author":"A Zehender","year":"2018","unstructured":"Zehender A et al (2018) The tyrosine phosphatase SHP2 controls TGF\u03b2-induced STAT3 signaling to regulate fibroblast activation and fibrosis. Nat Commun 9(1):3259","journal-title":"Nat Commun"},{"key":"4561_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fonc.2019.00321","volume":"9","author":"GA Palumbo","year":"2019","unstructured":"Palumbo GA et al (2019) The role of new technologies in myeloproliferative neoplasms. Front Oncol 9:321","journal-title":"Front Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04561-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04561-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04561-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T03:05:24Z","timestamp":1643857524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04561-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["4561"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04561-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"13 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures conducted in this study were in accordance with the ethical standards of our institutional research committee and with the 1964 World Medical Association Declaration of Helsinki and its later amendments or comparable ethical standards. The Medical Ethics Committee of Zhongnan Hospital, Wuhan University, reviewed and approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}